Day: March 18, 2020
TORONTO, March 18, 2020 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX FC) released its financial statements for the three and twelve months ended December 31, 2019.YEAR END HIGHLIGHTS
ORCHID ISLAND CAPITAL ANNOUNCES MARCH 2020 MONTHLY DIVIDEND AND FEBRUARY 29, 2020 RMBS PORTFOLIO CHARACTERISTICS
Written by Customer Service on . Posted in Public Companies.
March 2020 Monthly Dividend of $0.08 Per Share of Common StockRMBS Portfolio Characteristics as of February 29, 2020Next Dividend Announcement Expected April 8, 2020VERO BEACH, Fla., March 18, 2020 (GLOBE NEWSWIRE) — Orchid Island Capital, Inc. (the “Company”) (NYSE:ORC) announced today that the Board of Directors (the “Board”) declared a monthly cash dividend for the month of March 2020. The dividend of $0.08 per share will be paid April 28, 2020, to holders of record of the Company’s common stock on March 31, 2020, with an ex-dividend date of March 30, 2020. The Company plans on announcing its next common stock dividend after the Board’s meeting on April 8, 2020.The Company intends to make regular monthly cash distributions to its holders of common stock. In order to qualify as a real estate investment trust (“REIT”), the Company...
Novartis announces NEJM publication of three pivotal trials showing durable and potent efficacy of inclisiran, an investigational first-in-class siRNA cholesterol-lowering therapy
Written by Customer Service on . Posted in Public Companies.
Inclisiran, an investigational medicine, showed durable and potent reduction of low-density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk equivalents and heterozygous familial hypercholesterolemia (HeFH)1,2 Inclisiran reduced LDL-C at 17 months by 52% in patients with ASCVD (ORION-10), 50% for ASCVD and ASCVD risk equivalents (ORION-11) and by 50% in HeFH patients (ORION-9); all of whom had elevated LDL-C levels despite maximally tolerated lipid-lowering therapy1,2Inclisiran’s novel siRNA mechanism of action could potentially enable a unique twice-yearly subcutaneous dosing regimen administered by a healthcare providerInclisiran is currently under review by the U.S. Food and Drug Administration and European Medicines Agency for use in adults with ASCVD or HeFH who have elevated...
Marel: Results of the Annual General Meeting 18 March 2020
Written by Customer Service on . Posted in Public Companies.
Marel’s Annual General Meeting was a hybrid meeting held virtually and at the Company’s headquarters in Gardabaer, Iceland on 18 March 2020 at 16:00 GMT. All proposals of the Board of Directors to the meeting were approved. The proposals are accessible on the website of the meeting: https://marel.com/investors/shareholder-center/shareholder-meetings/Chairman of the Board Ásthildur Otharsdóttir addressed the meeting on behalf of the Board. CEO Árni Oddur Thórdarson reported the Company’s 2019 consolidated financial statements and gave an overview of the Company’s business activities.From Chairman Ásthildur Otharsdóttir’s statement:“These extraordinary times are a stark reminder of the importance of access to safe food for everyone. Looking beyond the global pandemic, feeding the world’s growing population is one of the biggest challenges...
Marel: Niðurstöður aðalfundar 18. mars 2020
Written by Customer Service on . Posted in Public Companies.
Aðalfundur Marel hf. var haldinn rafrænt og í höfuðstöðvum félagsins að Austurhrauni 9, 210 Garðabæ, þann 18. mars 2020 kl. 16:00. Allar tillögur stjórnar til aðalfundar voru samþykktar. Tillögurnar eru aðgengilegar á vefsíðu fundarins: https://marel.com/investors/shareholder-center/shareholder-meetings/Stjórnarformaður félagsins Ásthildur Otharsdóttir ávarpaði fundinn fyrir hönd stjórnar og Árni Oddur Þórðarson forstjóri gaf skýrslu um fjárhagsárið 2019 og veitti innsýn í starfsemi félagsins.„Þessir óvenjulegu tímar eru vægðarlaus áminning um það hversu mikilvægt aðgengi að öruggum matvælum er fyrir alla. Ef litið er framhjá þeim faraldri sem nú geisar er spurningin hvernig við fæðum ört vaxandi fólksfjölda ein af stærstu áskorunum sem heimurinn stendur frammi fyrir. Við verðum að finna nýjar leiðir til að framleiða hágæða matvæli á...
ROBEX DECLARES THE FIRST DIVIDEND IN ITS HISTORY
Written by Customer Service on . Posted in Public Companies.
QUEBEC CITY, March 18, 2020 (GLOBE NEWSWIRE) — Robex Resources Inc. (“Robex” or the “Company”) (TSXV: RBX) announces the first dividend payment in its history and declares an extraordinary dividend of $0.02 for each outstanding common share, payable on April 7, 2020.“The decision to pay a dividend for the first time reinforces our commitment to create value for all our shareholders,” said Mr. Georges Cohen, President. He added that “this important step in Robex’s development is a direct consequence of the wise choices underpinning the growth strategy implemented for several years by our experienced and seasoned management team. It is also a demonstration of the long lasting support and commitment of our foreign and local collaborators.”ADDITIONAL INFORMATION REGARDING THE EXTRAORDINARY DIVIDENDThe Company’s Board of Directors authorizes...
ROBEX DÉCLARE LE PREMIER DIVIDENDE DE SON HISTOIRE
Written by Customer Service on . Posted in Public Companies.
QUÉBEC, 18 mars 2020 (GLOBE NEWSWIRE) — Ressources Robex Inc. (« Robex » ou la « Société ») (TSXV: RBX) annonce le versement du premier dividende de son histoire et déclare un dividende extraordinaire de 2¢ pour chaque action ordinaire en circulation, payable le 7 avril 2020. « La décision de verser pour la première fois un dividende vient renforcer notre engagement à créer de la valeur pour tous nos actionnaires » déclare monsieur Georges Cohen, président. Il ajoute que « cette étape importante du développement de Robex reconnaît les choix avisés qui ont guidé les stratégies de gestion adoptées et mises en place par notre équipe de direction accomplie et chevronnée. Il reconnaît également le support de tous nos collaborateurs étrangers et locaux depuis plusieurs années. »INFORMATIONS SUPPLÉMENTAIRES A L’ÉGARD DU DIVIDENDE...
One Medical and Ascension Texas to Collaborate on Connecting Primary and Specialty Care
Written by Customer Service on . Posted in Public Companies.
AUSTIN, Texas and SAN FRANCISCO, March 18, 2020 (GLOBE NEWSWIRE) — One Medical is bringing its modernized, membership-based primary care model to Austin, and will partner with Ascension Texas to facilitate more seamless access and coordinated care across primary care and specialty care services.One Medical’s consumer-driven primary care platform combines seamless digital health and inviting in-office care convenient to where people work, shop, live and click. One Medical plans to launch in Austin with new medical office locations and its digital health services over the next 12 months, and will clinically and digitally integrate with Ascension Texas providers and sites of care in the community. Through this partnership, the two organizations aim to achieve greater care coordination between primary and specialty care settings, advance...
Altus Group Announces First Quarter 2020 Dividend
Written by Customer Service on . Posted in Public Companies.
TORONTO, March 18, 2020 (GLOBE NEWSWIRE) — Altus Group Limited (“Altus Group” or “the Company”) (TSX: AIF), a leading provider of software, data solutions and independent advisory services to the global commercial real estate industry, announced today that the Board of Directors has approved the payment of a cash dividend of $0.15 per common share for the first quarter ending March 31, 2020. Payment will be made on April 15, 2020 to common shareholders of record as at March 31, 2020.Altus Group’s Dividend Reinvestment Plan (“DRIP”) permits eligible shareholders to direct their cash dividends to be reinvested in additional common shares of the Company. For shareholders who wish to reinvest their dividends under the DRIP, Altus Group intends to issue common shares from treasury at a price equal to 96% of the weighted average closing...
Matas suspends financial guidance for 2019/20
Written by Customer Service on . Posted in Public Companies.
Company announcement no. 14 2019/20 – INSIDE INFORMATIONAllerød, 18 March 2020Matas suspends financial guidance for 2019/20In light of the current developments concerning the spread of COVID-19 and the Danish government’s decision to shut down parts of the retail sector, Matas has suspended its financial guidance for 2019/20.Since Wednesday, 11 March 2020, a number of measures aimed at curbing the spread of COVID-19 have been implemented in Denmark. These measures have reduced footfall in the retail sector at large, and in turn also to Matas’ physical stores, whereas the already strong online sales growth has gained additional momentum.In light of the Danish prime minister’s announcement on 17 March 2020 of the government’s decision to ban large crowds and shut down large parts of the retail sector, except for supermarkets, pharmacies...